Our study demonstrated that miR‐192 was significantly downregulated in glioma tissues and that this factor could inhibit MT in glioma cells through the EGR1‐HOXB9 loop while reducing their stemness and ultimately inhibiting their malignant phenotypes. This evidence concerns the gene EGR1 and central nervous system cancer.